Skip to content
Location Finder
Physician Login
Search
Investors
International
Careers
Search
Investors
International
Careers
Our Technology
SRT-100
SRT 100+
SRT-100 Vision
Benefits
Patient Benefits
Practice Benefits
Why Sensus?
Resources
Success Stories
Photo Gallery
FAQs
News
Clinical Studies
2026 Coding Updates – Q&A
Blog
About
Contact Us
Our Technology
SRT-100
SRT 100+
SRT-100 Vision
Benefits
Patient Benefits
Practice Benefits
Why Sensus?
Resources
Success Stories
Photo Gallery
FAQs
News
Clinical Studies
2026 Coding Updates – Q&A
Blog
About
Contact Us
SEC Filings
Investor Relations
Overview
Press Releases
SEC Filings
Stock Info
Events & Presentations
Governance
FAQs
Email Alerts
Overview
Press Releases
SEC Filings
Stock Info
Events & Presentations
Governance
FAQs
Email Alerts
Quarterly Reports
Latest Annual Report
All Filings
IN THE NEWS
CEO Joseph Sardano on Coding for Superficial Radiation Therapy
TUNE IN
About
About
Careers
Superficial Radiotherapy
Superficial Radiotherapy
Skin Cancer
Squamous Cell Carcinoma Treatment
Basal Cell Carcinoma Treatment
Alternative to Mohs Surgury
Keloid Treatment
Patient Outcomes
FAQ
News
Blog
sec filings
Contact
About
About
Careers
Superficial Radiotherapy
Superficial Radiotherapy
Skin Cancer
Squamous Cell Carcinoma Treatment
Basal Cell Carcinoma Treatment
Alternative to Mohs Surgury
Keloid Treatment
Patient Outcomes
FAQ
News
Blog
sec filings
Contact
SRT-100 LOCATOR
Physician Login
